Northwire Canada EditionThursday, July 23, 2026
Northwire
VZZ 0.180 +2.9% BMR 0.145 +3.6% NVO 0.055 −8.3% PMET 4.47 +2.0% CTG 0.125 +13.6% AVU 0.040 +0.0% SGML 14.32 −3.1% WRLG 0.720 +1.4% CAN 0.065 +8.3% ABRA 15.63 +1.6% LSTR 0.060 +0.0% OLA 13.10 +2.5% EQX 13.15 +2.7% SRA 0.780 +0.0% UTWO 0.390 −13.3% IVN 10.64 −1.2% VZZ 0.180 +2.9% BMR 0.145 +3.6% NVO 0.055 −8.3% PMET 4.47 +2.0% CTG 0.125 +13.6% AVU 0.040 +0.0% SGML 14.32 −3.1% WRLG 0.720 +1.4% CAN 0.065 +8.3% ABRA 15.63 +1.6% LSTR 0.060 +0.0% OLA 13.10 +2.5% EQX 13.15 +2.7% SRA 0.780 +0.0% UTWO 0.390 −13.3% IVN 10.64 −1.2%
M&A / Property

Fendx files patent application for catheter coating

FNDX · Price

Executive Summary

  • Fendx Technologies Inc. has filed a provisional patent application with the USPTO for a specialized lubricated coating for medical catheters and cannulas.
  • The technology aims to reduce friction for patient comfort and significantly lower microbial growth to decrease infection risks.
  • The patent was filed by Dr. Carolyn Myers, Tohid Didar, Martin Stark, and Leyla Soleymani, with Fendx as the assignee.

Key Details

  • Patent Filing: Provisional patent application filed with the United States Patent and Trademark Office.
  • Application Title: "Lubricated Dilated Medical Catheters and Cannula and Uses Thereof".
  • Filing Date: July 7, 2025.
  • Inventors: Dr. Carolyn Myers, Tohid Didar, Martin Stark, and Leyla Soleymani.
  • Assignee: Fendx Technologies Inc.
  • Technology Functionality:
    • Creates a low-friction surface to enhance patient comfort during insertion.
    • Reduces microbial growth on the catheter surface to mitigate infection risk.
  • Development Status: The company identified a specific coating candidate for further development based on prior analysis.
  • Product Pipeline Context: This coating is part of Fendx's broader hygiene-related technology portfolio, which includes an eco-friendly smart sponge, Repelwrap film, and spray-based coatings. The first coating in development is specifically for Foley catheters.

Notable Quotes

  • "We have been actively developing catheter coatings aimed at reducing bacterial growth, a major contributor to infection risk. Based on our analysis to date, we have identified a coating candidate for further development and have filed a provisional patent application to support its advancement," — Dr. Carolyn Myers, CEO of Fendx.
Read the original news release →

More from Fendx Technologies Inc